Report ID |
3233 |
Drug Identification Number |
02392534 |
Brand name |
GABAPENTIN TABLETS USP |
Common or Proper name |
GABAPENTIN |
Company Name |
ACCORD HEALTHCARE INC |
Market Status |
MARKETED |
Active Ingredient(s) |
GABAPENTIN |
Strength(s) |
800MG |
Dosage form(s) |
TABLET |
Route of administration |
ORAL |
Packaging size |
BOTTLE OF 100 TABS | BOUTEILLE DE 100 COMPRIMÉS |
ATC code |
N03AX |
ATC description |
ANTIEPILEPTICS |
Reason for shortage |
Disruption of the manufacture of the drug. |
Anticipated start date |
2016-12-06 |
Actual start date |
2016-12-06 |
Estimated end date |
2017-11-03 |
Actual end date |
2017-11-08 |
Shortage status |
Resolved |
Updated date |
2017-11-13 |
Company comments |
|
Health Canada comments |
|
Tier 3 Status |
No |
Company contact information |
Customer Service at (514) 505-4159 ext. 203 | Service à la clientèle à (514) 505-4159 poste 203 |